Related Experiment Video
Updated: Feb 15, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Stem cell-based therapy for α₁-antitrypsin deficiency
S Tamir Rashid1, David A Lomas
1Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 0XY, UK.
Human induced pluripotent stem cells can be generated in unlimited quantities for personalized transplants. This study demonstrates their potential for treating genetic disorders by correcting the Z-allele alpha-1-antitrypsin deficiency.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Genetic Medicine
Background:
- Human induced pluripotent stem cells (hiPSCs) offer a potential source of unlimited cells for autologous transplantation.
- Inherited genetic disorders represent a significant unmet medical need for novel therapeutic strategies.
Purpose of the Study:
- To provide proof of principle for using hiPSCs to treat inherited genetic disorders.
- To demonstrate the correction of the genetic defect in Z-allele alpha-1-antitrypsin deficiency using hiPSCs.
Main Methods:
- Generation and genetic correction of hiPSCs from patients with alpha-1-antitrypsin deficiency.
- In vitro characterization of corrected hiPSCs.
- Assessment of therapeutic potential for alpha-1-antitrypsin deficiency.
Main Results:
- Successful correction of the genetic defect underlying Z-allele alpha-1-antitrypsin deficiency in hiPSCs.
- Demonstration of the feasibility of using genetically corrected hiPSCs for potential autologous transplantation.
- Establishment of a proof-of-concept for hiPSC-based therapy in inherited genetic disorders.
Conclusions:
- Human induced pluripotent stem cells hold promise for treating inherited genetic disorders.
- Correction of genetic defects in hiPSCs is achievable.
- Further research is needed to address safety concerns for clinical translation.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Factors Affecting α-Alkylation of Ketones: Choice of Base
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence,...
Adult Stem Cells
Base-Promoted α-Halogenation of Aldehydes and Ketones
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

